CD274 and ductal breast carcinoma in situ: Thompson reported 81% of the DCIS lesions contained PD-L1+ immune cells, Hendry reported 25% of cases with PD-L1+ immune cells, and we observed 44% of the DCIS cases with significant PD-L1+ T cells or macrophages.